You are viewing: Europe Remote Patient Monitoring (RPM) Market analysis

The Europe Remote Patient Monitoring (RPM) Market was valued at $5431.7 Million in 2026 and projected to reach to $8707.6 Million by 2031, representing a compound annual growth rate of 9.9%. Europe's Remote Patient Monitoring market is poised for sustained growth as healthcare systems increasingly embrace digital transformation to address aging populations and chronic disease burdens.

Europe Remote Patient Monitoring (RPM) Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Remote Patient Monitoring (RPM) Market Trends and Insights

  • This 9.9% compound annual growth rate reflects Europe's commitment to digital health transformation and aging population management.
  • Europe is leveraging RPM technologies to enhance chronic disease management, reduce hospital readmissions, and improve patient outcomes across diverse healthcare systems. The European RPM market benefits from strong regulatory frameworks, including GDPR compliance and CE marking requirements, which foster trust in digital health solutions.
  • Europe's healthcare providers are increasingly adopting RPM platforms to address workforce shortages and optimize resource allocation.
  • Between 2026 and 2031, Europe is expected to see accelerated adoption driven by reimbursement policies, interoperability standards, and integration with electronic health records across member states. Europe's market growth is supported by rising prevalence of chronic conditions, aging demographics, and government initiatives promoting remote care delivery.
  • The region's emphasis on patient-centric care and preventive medicine positions Europe as a key growth market for RPM solutions globally..

Key Market Statistics

  • CAGR (2026-2031) 9.9% CAGR
  • Market Size, 2026 ~USD 5431.7 Million
  • Forecast, 2031 ~USD 8707.6 Million
  • Geography Europe

Europe Remote Patient Monitoring (RPM) Market Overview

Market Valuation & Growth :

Europe's RPM market is valued at $5,431.7 million in 2026, expanding to $8,707.6 million by 2031, representing a robust 9.9% CAGR driven by digital health adoption and regulatory support across EU member states.

Aging Population Management :

Europe's aging demographic is accelerating RPM adoption for chronic disease management, particularly in Germany, UK, and France, where healthcare systems prioritize cost-effective monitoring solutions to reduce hospital readmissions.

Digital Health Infrastructure :

Strong healthcare IT infrastructure and GDPR-compliant data management frameworks position Europe as a leader in secure RPM implementation, fostering trust among patients and healthcare providers across the continent.

Regional Market Leadership :

Germany dominates Europe's RPM market with $3,553.8 million, followed by the UK ($2,490.1 million) and France ($2,286.1 million), reflecting advanced healthcare systems and high digital adoption rates in Western Europe.

Europe Remote Patient Monitoring (RPM) Market Dynamics

  • Government initiatives promoting telemedicine, combined with favorable reimbursement policies in major markets like Germany and the UK, are accelerating RPM adoption across hospitals, clinics, and home care settings.
  • The integration of AI-driven analytics and wearable technologies is enhancing patient outcomes while reducing healthcare costs. By 2031, Europe's RPM market will reach $8,707.6 million, driven by regulatory harmonization across EU nations, increased investment in digital health infrastructure, and growing patient acceptance of remote monitoring solutions.
  • Key growth catalysts include chronic disease prevalence, workforce shortages in healthcare, and the shift toward value-based care models.
  • European healthcare providers are leveraging RPM to improve operational efficiency and patient engagement, positioning the region as a mature and competitive market for innovative monitoring technologies..

Related Ecosystem

Cardiovascular Devices

Top Technologies
    Top Companies

      Diagnostic Imaging

      Top Technologies
        Top Companies

          Healthcare It

          Top Technologies
            Top Companies

              Key Takeaways

              • Europe's RPM market will grow from $5,431.7M (2026) to $8,707.6M (2031) at a 9.9% CAGR, driven by digital health adoption and aging populations.
              • Europe's regulatory environment, including GDPR and CE marking, creates competitive advantages for compliant RPM vendors in the region.
              • European healthcare systems are prioritizing RPM to address chronic disease management, workforce shortages, and hospital capacity constraints.
              • Reimbursement policy alignment and EHR integration across European member states will accelerate RPM adoption through 2031.

              Remote Patient Monitoring (RPM) Market Report Scope

              Report Metric Details
              Base Year 2026
              Fastest Growing Segment SYNCHRONOUS (Transmission Type)
              Forecast Period 2026–2031
              Growth Rate CAGR of 12.8% from 2026 to 2031
              Largest Segment HEALTHCARE PROVIDERS (End User)
              Market Size Base Year (Billions) ~USD 36.32 (2026)
              Revenue Forecast (Billions) ~USD 66.33 (2031)
              Segments Covered Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type

              Europe Remote Patient Monitoring (RPM) Market Report Segmentation

              8 segment dimensions are covered across the global market.

              By Component

              • Devices
              • Services
              • Software

              By Function

              • Blood Glucose Monitoring
              • Cardiac Monitoring
              • Fetal & Neonatal Monitoring
              • Multiparameter Monitoring
              • Neurological Monitoring
              • Other Monitoring Devices
              • Pulse Oximeters
              • Respiratory Monitoring
              • Thermometers
              • Weight Monitoring

              By Type

              • Ambulatory Surgical Centers, Ambulatory Care Centers, And Other Outpatient Settings
              • Handheld & Portable
              • Handheld & Portable Devices
              • Home Healthcare
              • Hospitals
              • Implantable
              • Implantable Devices
              • Long-Term Care & Assisted Living Facilities
              • Other Healthcare Providers
              • Others (Stationary Devices And Others)
              • Others (Stationary Devices, And Others)
              • Wearable
              • Wearable Devices

              By Deployment Model

              • Cloud-Based Model
              • On-Premise Model

              By Transmission Type

              • Asynchronous
              • Synchronous

              By Indication

              • Cardiology
              • Diabetes
              • Mental Health
              • Neurology
              • Oncology
              • Other Indications
              • Respiratory Disorders
              • Sleep Disorders
              • Wellness Improvement

              By End User

              • Healthcare Payers
              • Healthcare Providers
              • Medtech Companies
              • Other End Users
              • Patients
              • Pharmaceutical & Biotechnology Companies

              By Deployment Type

              • Cloud-Based
              • On-Premises

              Target Audience

              • Healthcare Technology Vendors : RPM solution providers need Europe-specific market data to identify high-potential countries, tailor product offerings to regional regulations, and develop localized go-to-market strategies for competitive positioning.
              • Hospital & Healthcare Systems : European healthcare providers require market insights to evaluate RPM technology investments, benchmark adoption rates against peers, and optimize chronic disease management programs within budget constraints.
              • Private Equity & Investment Firms : Investors targeting European healthcare technology need detailed market sizing, growth forecasts, and country-level analysis to identify acquisition targets and assess portfolio company expansion opportunities.
              • Government & Health Policy Makers : EU and national health authorities use market data to inform digital health policy, reimbursement frameworks, and infrastructure investments that support RPM adoption and healthcare system modernization.
              • Pharmaceutical & Medical Device Companies : Pharma and device manufacturers need RPM market intelligence to develop companion monitoring solutions, understand patient engagement trends, and identify partnership opportunities with European healthcare providers.

              Key Companies in the Europe Remote Patient Monitoring (RPM) Market

              CompanyHQOwnershipStrongest segments
              KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health,
              MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring),
              GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
              ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
              ORACLEUnited StatesPublic CompanyCloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain),
              BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
              NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices,
              SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
              BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),

              KONINKLIJKE PHILIPS N.V.

              Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.

              MEDTRONIC

              Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.

              GE HEALTHCARE

              GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.

              ABBOTT

              Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.

              ORACLE

              Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.

              BOSTON SCIENTIFIC CORPORATION

              Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.

              NIHON KOHDEN CORPORATION

              Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.

              SIEMENS HEALTHINEERS AG

              Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.

              BAXTER

              Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.

              Europe vs. other regions

              HowEurope compares to the other 3 regional blocs covered in this market.

              North America
              ~USD 23802 Million · 12% wtd CAGR ·
              Asia Pacific
              ~USD 10093.7 Million · 14.9% wtd CAGR ·
              Latin America
              ~USD 1642.7 Million · 12.7% wtd CAGR ·
              Middle East & Africa
              ~USD 852.3 Million · 9.5% wtd CAGR ·

              Countries within Europe - compare and drill down

              Country2025 size (native)
              GermanyUSD 3553.8 Million
              UKUSD 2490.1 Million
              FranceUSD 2286.1 Million
              ItalyUSD 1093.2 Million
              SpainUSD 846 Million
              Rest Of EuropeUSD 2536.1 Million

              Country market size visualization

              Germany
              USD 3553.8 Million
              UK
              USD 2490.1 Million
              France
              USD 2286.1 Million
              Italy
              USD 1093.2 Million
              Spain
              USD 846 Million
              Rest Of Europe
              USD 2536.1 Million

              Reasons to Buy this Report

              • Market-Specific Sizing & Forecasts : Access precise valuation data for Europe's RPM market ($5.4B in 2026, $8.7B in 2031) with country-level breakdowns for Germany, UK, France, Italy, and Spain to inform regional investment and expansion strategies.
              • Competitive Landscape Intelligence : Understand market dynamics across Europe's leading healthcare economies, identifying growth opportunities in mature Western European markets and emerging potential in Rest of Europe segment ($2.5B market).
              • Regulatory & Reimbursement Insights : Gain clarity on GDPR compliance, EU digital health directives, and country-specific reimbursement policies that shape RPM adoption rates and pricing strategies across European healthcare systems.
              • Strategic Market Positioning : Benchmark your RPM solutions against regional competitors and identify high-growth segments within Europe's aging population management, chronic disease monitoring, and hospital readmission reduction initiatives.
              • Investment Decision Support : Make data-driven decisions on market entry, partnerships, and resource allocation in Europe by leveraging detailed CAGR analysis (9.9%) and country-specific growth trajectories through 2031.

              Frequently asked questions

              What is the current size of Europe's Remote Patient Monitoring market?

              Europe's RPM market is valued at $5,431.7 million in 2026 and is projected to reach $8,707.6 million by 2031.

              What is the expected growth rate for Europe's RPM market?

              Europe's RPM market is expected to grow at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2031.

              What regulatory factors influence Europe's RPM market?

              Europe's RPM market is shaped by GDPR data protection requirements, CE marking standards, and national healthcare regulations that ensure patient privacy and device safety.

              Which healthcare challenges are driving RPM adoption in Europe?

              Europe's healthcare systems are adopting RPM to manage aging populations, reduce chronic disease burden, address physician shortages, and optimize hospital resource utilization.

              How will Europe's RPM market evolve by 2031?

              Europe's RPM market will expand through increased reimbursement coverage, standardized interoperability protocols, deeper EHR integration, and government-backed digital health initiatives across member states.

              RESEARCH METHODOLOGY

              The study involved major activities in estimating the current market size for the remote patient monitoring market.

              Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.  

              Secondary Research

              In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

              Primary Research

              Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

              BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS

              Remote Patient Monitoring Market 
 Size, and Share

              Note 1: Others include sales managers, marketing managers, and product managers.

              Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

              To know about the assumptions considered for the study, download the pdf brochure

              Market Size Estimation

              Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

               The research methodology used to estimate the market size includes the following:

              Remote Patient Monitoring Market Top Down and Bottom Up Approach

              Data Triangulation

              After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.

              Market Definition

              The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.

              Key Stakeholders

              • RPM Equipment and devices Manufacturers
              • Suppliers and Distributors of RPM Equipment
              • RPM software provider
              • Healthcare IT Service Providers
              • Healthcare Insurance Companies/Payers
              • Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
              • Venture Capitalists
              • Government Bodies/Regulatory Bodies
              • Corporate Entities
              • Accountable Care Organizations
              • RPM Resource Centers
              • Research and Consulting Firms
              • Medical Research Institutes
              • Clinical Departments

              Report Objectives

              • To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
              • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
              • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
              • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
              • To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
              • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
              • To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.

              Available customizations:

              With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

              • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
              • Geographic Analysis:  Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries

               

              Get the Full Remote Patient Monitoring (RPM) Market Report

              Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.

              Need a Tailored Report?

              Customize this report to your needs

              Get 10% FREE Customization

              Customize This Report
              Fact checked
              DMCA.com Protection Status